Login or Register to make a submission.

Submission Preparation Checklist

As part of the submission process, authors are required to check off their submission's compliance with all of the following items, and submissions may be returned to authors that do not adhere to these guidelines.
  • The manuscript has not been previously published or sent for consideration to any other publication.
  • The main document is in Microsoft Word, RTF, or WordPerfect format.
  • Manuscript is double-spaced with ample margins on all sides, and with numbered pages, following the ICMJE Uniform Requirements. The tables are included in the main document after the references.
  • Title Page. The first page should contain the full title, a brief running title (not to exceed 40 characters), full name of author(s), institutional affiliation of author(s), and name, mailing address, fax and e-mail of the author to whom all correspondence should be directed.
  • The summary should be organised with the following subheadings: Background, Objectives, Methods, Results and Conclusions and should not exceed 250 words.
  • Three to ten key words or brief phases.
  • The references should follow the norms of ICMJE (see the instructions to authors in our web site www.jiaci.org), but including all the authors (et al is not sufficient).
  • Figures are in a different document (tif), and their legends in a separate page in the manuscript, after the references.
  • References are numbered consecutively throughout the text and enclosed in square brackets placed before punctuation.
  • JIACI requires all authors to declare any conflicts of interest that may be inherent in their submission.

Author Guidelines

The Journal of Investigational Allergology & Clinical Immunology will consider for publication those papers directly related to allergology and clinical and experimental immunopathology. In general, the journal subscribes to the Uniform Requirements for Manuscripts Submitted to Biomedical Journals (henceforth the Uniform Requirements) of the International Committee of Medical Journal Editors (ICMJE): http://www.icmje.org . Further specifications follow. The Journal will comprise the following major sections: Original Articles. Original research papers in allergy and immunopathology, new forms of therapy for allergic and immune disorders, new applications of diagnostic methods, and clinical and experimental studies on the immunopathogenesis of allergic diseases and immune disorders are welcome. Note that a report of a case series may be considered an original article only if there is an explicit objective that motivated the retrospective or prospective (cohort) study, which should include appropriate statistical treatment of the data. Advice on appropriate sectioning of original articles can be found in the ICMJE’s Uniform Requirements. In those requirements, it is also recommended that certain study designs follow particular structures for optimum reporting; links to those specific recommendations can be obtained from the ICMJE website. They are the CONSORT statement for randomized controlled trials, the STARD statement for studies of diagnostic accuracy, the QUOROM statement for systematic reviews and meta-analyses of trials, the STROBE statement for observational studies, and the MOOSE statement for systematic analyses and meta-analyses of observational studies. Practitioner´s corner These short papers, which are intended for rapid publication, follow the same structures as longer original articles or case reports described above but do not use subheadings or include an abstract. The text is strictly limited to less than 1000 words (please supply a word count), up to 10 references, 1 figure or table, and up to 5 key words. Editorials and Review Articles. Contributions from specialists in the field are requested by the Editors. Unsolicited reviews will be subject to consideration by the Editorial Board or subject to peer review at the Board’s discretion. Letters to the Editor. Comments on articles published in J Investig Allergol Clin Immunol are welcome. The letter will be sent to the author of the related article, who will have 4 weeks to answer. After the reply, no further correspondence will be accepted. Letters will be reviewed by the Editorial Board or subject to peer review at the Board’s discretion Submission of Manuscripts Manuscripts can be submitted as a Microsoft Word file or a rich text format (RTF) file at the website http://recyt.fecyt.es/index.php/JIACI/index . File names should include the corresponding author’s surname. Each figure should be in a separate document, and the file name for each should include the corresponding author’s surname and a key word that indicates the figure number and manuscript it pertains to. File names should include the corresponding author’s surname. Each figure should be in a separate document, and the file name for each should include the corresponding author’s surname and a key word that indicates the figure number and manuscript it pertains to. Author Assurances. A cover letter requesting review by the Editorial Board for publication in the journal should accompany the manuscript and include a statement by the authors(s) confirming that the manuscript has not been published elsewhere and is not under consideration for publication elsewhere, as well as a statement of consent from all the authors. Conflicts of interest Authors must disclose any financial or personal relationship which could result in a conflict of interest with regard to the published article. Even if the authors consider that there is none, they must declare it. All manuscripts accepted for publication remain the property of the J Investig Allergol Clin Immunol and are subject to copyright restrictions regarding reproduction. Manuscripts published in or submitted to another journal cannot be considered. Preparation of Manuscripts Manuscripts should be typewritten, double-spaced with ample margins on all sides, and with numbered pages, following the ICMJE Uniform Requirements. The word limits for the body of the text, not including abstract, figure legends, or references are as follows: original articles, 3500 words; reviews 7500;short communications, brief case notes and letters, 1000. (Please supply a word count on the title page.) Title Page. The first page should contain the full title, a brief running title (not to exceed 40 characters), full name of author(s), institutional affiliation of author(s), and name, mailing address, fax and e-mail of the author to whom all correspondence should be directed. Note the word count and the number of tables and figures. If data have been presented in abstract or poster form at conferences, this information should be noted after the title page, as should funding sources for the study or any author conflicts of interest. Abstract. Original articles and reviews require abstracts. The major points of the article should be summarized in 250 words (original and review articles), in the order of their appearance in the manuscript. Material or facts not cited in the full manuscript should not be included in the abstract. The abstract of an original article should be organized with the following subheadings: Background (optional), Objective(s), Methods (or Material and Methods or Patients and Methods, as appropriate), Results, Conclusion(s). Such structuring is unnecessary for reviews. Key Words. Three to 8 key words or brief phrases should be included after the abstract for indexing purposes. The Medical Subject Headings used by the US National Library of Medicine’s Index Medicus (MEDLINE) are preferred. Main Text. For original articles, authors should follow the ICMJE Uniform Requirements for structuring their articles into sections and subsections, as mentioned above. Tables. Each table should be typed on a separate page after the references. Authors are requested, whenever possible, to construct tables that can be arranged on the page and read in the same direction as the text. Titles should not exceed two lines. Information appearing in fi gures or text should not be included in tables. Figures. Figures should illustrate important results, and they should be cited in the text. Line artwork (such as graphs) should be submitted as TIFF files, with a minimum resolution of 800 dpi. Other artwork (such as photographs) should be submitted as 250-300 dpi TIFF fi les. Legends should be included on a separate page in the manuscript, after the references. Acknowledgments. When necessary, credit should be given to persons, centers or foundations who have collaborated in the study. Please also acknowledge help received in preparation of the manuscript (editing services, translation, or other) or statistical analysis. Refer to advice in the ICMJE’s Uniform Requirements. References. All references should be numbered consecutively throughout the text and enclosed in square brackets placed before punctuation. Journal abbreviations in the reference list should be those of the US National Library of Medicine’s Index Medicus. (See a few examples below.) Complete citation of all the author(s) name(s) should be followed by the complete title of the paper, abbreviated journal title, year, volume, and first and last page number. When citing a chapter from a book, the author(s) name(s) should be followed by the complete title of the paper, title of the book, volume number, editor(s) name(s), address and name of the publisher, year, and first and last page numbers: References (with the exception of review articles) should be limited to approximately 35 for original articles and 10 for the Practitioner's Corner. Authors should not submit manuscripts in which Microsoft Word footnoting tools have been used to insert references; if other reference management software is used, authors should remove the hyperlinks before submitting the manuscript. Following are 3 examples of reference presentation forms. For additional examples, see the US National Library of Medicine’s complete list: http://www.nlm.nih.gov/bsd/uniform_requirements.html . 1. Parameswaran K, Radford K, Zuo J, Janssen LJ, O’Byrne PM, Cox PG. Extracellular matrix regulates human airway smooth muscle cell migration. Eur Respir J. 2004;24:545-51. 2. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention NIH Pub. No 02-3659, January 1995. Updated 2005. [cited 2006 Oct 24]. Available from: www. ginasthma.com. 3. Marsh DG. Genetic and molecular analysis of human immune responsiveness to allergens. In: Marsh DG, Lockhart A, Holgate ST, editors. The genetics of asthma. Oxford: Blackwell Scientific Publications; 1993. p. 201-13. Copyediting and Proofreading The corresponding author will be contacted by a copyeditor while the manuscript is being prepared for publication, so that the author can approve any modifications suggested. Furthermore, the corresponding author will receive the copyedited manuscript by e-mail with proposed modifications marked on the fi le, for approval or correction. This process should ensure that the manuscript is both correct and readable, to the author’s satisfaction. If the author is unavailable during this process, publication delay may result. A minimal number of changes should be necessary on page proofs, which will be sent to the same corresponding author a few weeks later. Proofs, particularly tables and figures, should be checked against the original manuscript. Authors will be charged for major alterations in the original text, so attention should be given during the copyediting phase. Proofs not returned in time to meet the publication date will either be rescheduled or published without the authors’ corrections, in which case the Editors do not assume responsibility for any errors that might have been made in typesetting.

Privacy Statement

In accordance with the provisions of Article 5 from Organic Law 15/1999, dated 13th December, concerning the Protection of Personal Data, we wish to inform you that personal information provided to the journals to which FECYT provides access is included in a file belonging to the journal “Journal of Investigational Allergology and Clinical Immunology”. It is possible to check each journal’s purpose in the section “about/contact”.

We also inform you that FECYT acts as data processor for each of the files owned by the journals. Thereof, FECYT facilitates the exercise of your rights of access, rectification, cancellation and opposition, according to the terms described in Spanish Law on the Protection of Personal Data, by contacting the Spanish Foundation for Science and Technology headquarters located at C/ Pintor Velázquez nº 5 - Edificio Museo Nacional de Ciencia y Tecnología, 28100 Alcobendas (Madrid).

Disclaimer and privacy policy available following this link